CardioGenics Holdings Inc (CGNH)
USD 0.0
(99.0%)
USD 0.0
(99.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 1297.00 USD | -85.39% |
| 2011 | 8876.00 USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 21.53 Thousand USD | -87.84% |
| 2008 | 177.06 Thousand USD | -12.9% |
| 2007 | 203.28 Thousand USD | 21.95% |
| 2006 | 166.69 Thousand USD | -30.44% |
| 2005 | 239.65 Thousand USD | -5.37% |
| 2004 | 253.25 Thousand USD | -34.37% |
| 2003 | 385.88 Thousand USD | -38.23% |
| 2002 | 624.67 Thousand USD | -37.62% |
| 2001 | 1 Million USD | -3.89% |
| 2000 | 1.04 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2012 Q1 | 1136.00 USD | -54.12% |
| 2012 Q4 | 161.00 USD | 0.0% |
| 2012 FY | 1297.00 USD | -85.39% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | -100.0% |
| 2011 FY | 8876.00 USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | 2476.00 USD | -61.31% |
| 2011 Q3 | 6400.00 USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q1 | 41.65 Thousand USD | -2.82% |
| 2009 FY | 21.53 Thousand USD | -87.84% |
| 2009 Q4 | 21.53 Thousand USD | 0.0% |
| 2009 Q2 | 32.26 Thousand USD | -22.55% |
| 2009 Q3 | - USD | -100.0% |
| 2008 Q3 | 57.32 Thousand USD | 39.48% |
| 2008 Q1 | 41.9 Thousand USD | 14.08% |
| 2008 FY | 177.06 Thousand USD | -12.9% |
| 2008 Q4 | 42.86 Thousand USD | -25.24% |
| 2008 Q2 | 41.1 Thousand USD | -1.91% |
| 2007 FY | 203.28 Thousand USD | 21.95% |
| 2007 Q4 | 36.73 Thousand USD | -5.76% |
| 2007 Q3 | 38.97 Thousand USD | -38.3% |
| 2007 Q2 | 63.17 Thousand USD | 9.28% |
| 2007 Q1 | 57.8 Thousand USD | 33.41% |
| 2006 Q4 | 43.33 Thousand USD | 85.75% |
| 2006 Q3 | 23.32 Thousand USD | -59.97% |
| 2006 Q2 | 58.26 Thousand USD | 29.27% |
| 2006 Q1 | 45.07 Thousand USD | 12.62% |
| 2006 FY | 166.69 Thousand USD | -30.44% |
| 2005 Q1 | 45.46 Thousand USD | -37.06% |
| 2005 FY | 239.65 Thousand USD | -5.37% |
| 2005 Q4 | 40.02 Thousand USD | -32.16% |
| 2005 Q3 | 59 Thousand USD | -6.29% |
| 2005 Q2 | 62.96 Thousand USD | 38.5% |
| 2004 Q2 | 56.6 Thousand USD | -24.09% |
| 2004 FY | 253.25 Thousand USD | -34.37% |
| 2004 Q4 | 72.22 Thousand USD | -4.61% |
| 2004 Q1 | 74.56 Thousand USD | 60.79% |
| 2004 Q3 | 75.71 Thousand USD | 33.76% |
| 2003 Q1 | 116 Thousand USD | -7.16% |
| 2003 Q4 | 46.37 Thousand USD | -37.57% |
| 2003 FY | 385.88 Thousand USD | -38.23% |
| 2003 Q3 | 74.28 Thousand USD | 5.14% |
| 2003 Q2 | 70.64 Thousand USD | -39.1% |
| 2002 Q3 | 156.71 Thousand USD | 138.39% |
| 2002 Q2 | 65.73 Thousand USD | -70.01% |
| 2002 Q1 | 219.22 Thousand USD | 19.8% |
| 2002 FY | 624.67 Thousand USD | -37.62% |
| 2002 Q4 | 124.95 Thousand USD | -20.27% |
| 2001 FY | 1 Million USD | -3.89% |
| 2001 Q3 | 257.63 Thousand USD | 91.77% |
| 2001 Q2 | 134.34 Thousand USD | -61.15% |
| 2001 Q1 | 345.8 Thousand USD | 31.15% |
| 2001 Q4 | 182.99 Thousand USD | -28.97% |
| 2000 Q1 | 321.59 Thousand USD | 0.0% |
| 2000 FY | 1.04 Million USD | 0.0% |
| 2000 Q4 | 263.68 Thousand USD | 25.47% |
| 2000 Q2 | 204.17 Thousand USD | -36.51% |
| 2000 Q3 | 210.15 Thousand USD | 2.93% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | 100.0% |
| Arrayit Corporation | 4.37 Million USD | 100.0% |
| Atlantic International Corp. | - USD | NaN% |
| Biocept, Inc. | 25.85 Million USD | 100.0% |
| Bioqual, Inc. | 58.59 Million USD | 100.0% |
| DermTech, Inc. | 15.29 Million USD | 100.0% |
| Global WholeHealth Partners Corporation | - USD | NaN% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 100.0% |
| iMD Companies, Inc. | - USD | NaN% |
| IDenta Corp. | 1.05 Million USD | 100.0% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | 100.0% |
| InVitro International | 792.62 Thousand USD | 100.0% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | - USD | NaN% |
| Medical Imaging Corp. | 7.22 Million USD | 100.0% |
| NovelStem International Corp. | 12 Thousand USD | 100.0% |
| Optigenex Inc. | 465.97 Thousand USD | 100.0% |
| PharmChem, Inc. | 6.01 Million USD | 100.0% |
| Proteome Sciences plc | 6.4 Million USD | 100.0% |
| Response Genetics, Inc | 18.04 Million USD | 100.0% |
| Rennova Health, Inc. | 13.03 Million USD | 100.0% |
| RushNet, Inc. | 1.78 Million USD | 100.0% |
| ScreenPro Security Inc. | 1.91 Million USD | 100.0% |
| Stella Diagnostics Inc. | - USD | NaN% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | 100.0% |
| Todos Medical Ltd. | 7.69 Million USD | 100.0% |